Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitors (Tenofovir DF + Lamivudine)
Non-Nucleoside Reverse Transcriptase Inhibitor (Efavirenz)

Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.

Dosage & Administration
One tablet once daily, preferably at bedtime, or as prescribed by a healthcare professional.

To be used strictly as part of an ART regimen in line with treatment guidelines.

Storage
Store below 30°C in a dry place, protected from light and moisture.

Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.